⚠️ This AI-generated report synthesizes publicly available information. AI can make mistakes. Please double check information in this report.
Consumer Defensive | Household & Personal Products
📊 The Bottom Line
Colgate-Palmolive is a global consumer defensive giant with strong brand recognition in oral, personal, home care, and pet nutrition. Its extensive international presence provides a stable revenue base and consistent dividend payouts, appealing to long-term income-focused investors. The business quality is solid, but growth is moderate.
⚖️ Risk vs Reward
At US$87.26, CL trades at a premium valuation compared to its historical averages and some peers. Analyst targets suggest modest upside to US$95.47, implying the current price fully reflects its stable cash flows and brand strength. Risk/reward appears balanced, favoring stability over aggressive growth.
🚀 Why CL Could Soar
⚠️ What Could Go Wrong
Oral Care
45%
Flagship segment including toothpaste, toothbrushes, and mouthwash.
Pet Nutrition
25%
Premium pet food products for daily and therapeutic needs.
Personal & Home Care
30%
Diverse range of soaps, shampoos, detergents, and household cleaners.
🎯 WHY THIS MATTERS
Colgate-Palmolive's diversified portfolio across essential consumer goods and pet care provides resilience during economic downturns, as demand for these products remains relatively stable. Its strong brand presence and global distribution network in over 200 countries reinforce its market position and revenue predictability, allowing for consistent cash flow generation.
Colgate-Palmolive boasts globally recognized brands like Colgate, Palmolive, and Hill's, fostering deep consumer trust and loyalty. This strong brand equity allows for premium pricing, high market share in key categories (like oral care), and resilience against new entrants, creating a consistent and predictable revenue stream across diverse geographies. This makes it difficult for new competitors to quickly gain traction.
Operating in over 200 countries, Colgate-Palmolive has an unparalleled global supply chain and distribution network. This allows for efficient market penetration, reaching diverse consumer bases from traditional retail to modern e-commerce. This vast reach provides a significant barrier to entry for smaller competitors and enables the company to scale new products quickly and effectively worldwide.
The company consistently invests in R&D to innovate in high-margin segments like premium pet nutrition (Hill's) and advanced skin health (EltaMD, Filorga). This focus on differentiated, value-added products helps drive growth and enhances profitability, moving beyond basic commodity goods. This strategic shift towards premiumization allows for higher pricing and strengthens competitive positioning in growing segments.
🎯 WHY THIS MATTERS
These competitive advantages collectively ensure Colgate-Palmolive's long-term stability and profitability. The combination of deeply ingrained brand loyalty, vast market reach, and targeted innovation allows the company to defend its market share, command pricing power, and navigate competitive pressures effectively, contributing to its status as a consumer defensive leader.
Noel R. Wallace
Chairman, CEO & President
Noel R. Wallace, 61, leads Colgate-Palmolive as Chairman, CEO, and President. With a long tenure at the company, he has been instrumental in focusing on strategic growth areas like pet nutrition and premium skin health, driving global market expansion, and emphasizing brand investment to maintain competitive edge and deliver consistent shareholder returns.
The household and personal products industry is highly competitive, characterized by established global players and growing local brands. Competition revolves around brand loyalty, product innovation, pricing, and extensive distribution networks. Companies continually invest in marketing and R&D to maintain relevance and market share, responding to evolving consumer preferences and market dynamics.
📊 Market Context
Competitor
Description
vs CL
Procter & Gamble (PG)
A multinational consumer goods corporation with a vast portfolio spanning beauty, grooming, health care, and fabric and home care products.
P&G is a direct competitor across many categories, known for its extensive brand portfolio and strong marketing. It often competes on innovation and brand strength, similar to Colgate-Palmolive, but with broader product diversification.
Unilever PLC (UL)
A British multinational consumer goods company co-headquartered in London, England. Its products include food, condiments, ice cream, wellbeing, personal care, and cleaning agents.
Unilever competes directly in personal care and home care segments. Known for its strong presence in emerging markets and focus on sustainability, it offers a wider range of food products, distinguishing its overall portfolio from Colgate-Palmolive's.
Kimberly-Clark Corporation (KMB)
An American multinational personal care corporation that produces mostly paper-based consumer products, such as sanitary paper products.
Kimberly-Clark primarily competes in hygiene and tissue product categories, such as diapers, wipes, and paper towels. While it overlaps in some personal care areas, its core focus is different from Colgate-Palmolive's oral care and pet nutrition strength.
1
7
6
6
Low Target
US$79
-9%
Average Target
US$95
+9%
High Target
US$105
+20%
Closing: US$87.26 (1 May 2026)
High Probability
Colgate's array of leading brands allows it to implement strategic price increases without significant volume loss, bolstering revenue and protecting margins even amidst inflationary pressures, supporting consistent earnings growth.
Medium Probability
Continued penetration and expansion in high-growth emerging markets, which already account for a significant portion of sales, can provide a substantial runway for organic revenue growth, offsetting maturity in developed markets.
High Probability
The Hill's pet nutrition segment, with its focus on veterinary and specialty channels, commands higher margins. Further innovation and market share gains in this premium category could disproportionately boost overall profitability and shareholder value.
High Probability
Aggressive competition from well-funded rivals and the rise of private-label brands could lead to pricing wars, eroding market share and compressing profit margins across key product categories, impacting overall profitability.
Medium Probability
With 70% of sales from international markets, adverse currency movements and economic instability in major regions could significantly negatively impact reported revenues and profitability when translated to USD, affecting financial performance.
Medium Probability
Persistent inflation in raw materials, packaging, and logistics, coupled with potential supply chain bottlenecks, could increase operating expenses, challenging the company's ability to maintain its gross margins and profitability levels.
For long-term investors, Colgate-Palmolive offers stability due to its indispensable products and strong global brands. The company's consistent dividend and defensive nature are appealing. However, CL needs to demonstrate continued innovation to fend off fierce competition and navigate currency headwinds. The ability to grow in emerging markets and expand its premium segments, particularly pet nutrition, will be crucial for sustained long-term value creation beyond current market share, justifying a decade-long hold.
Metric
31 Dec 2025
31 Dec 2024
31 Dec 2023
Income Statement
Revenue
US$20.38B
US$20.10B
US$19.46B
Gross Profit
US$12.25B
US$12.16B
US$11.33B
Operating Income
US$4.23B
US$4.33B
US$4.08B
Net Income
US$2.13B
US$2.89B
US$2.30B
EPS (Diluted)
2.63
3.51
2.77
Balance Sheet
Cash & Equivalents
US$1.29B
US$1.10B
US$0.97B
Total Assets
US$16.33B
US$16.05B
US$16.39B
Total Debt
US$8.55B
US$8.51B
US$9.06B
Shareholders' Equity
US$0.05B
US$0.21B
US$0.61B
Key Ratios
Gross Margin
60.1%
60.5%
58.2%
Operating Margin
20.8%
21.5%
21.0%
Return on Equity
3948.15
1362.74
377.67
Metric
Annual (31 Dec 2026)
Annual (31 Dec 2027)
EPS Estimate
US$3.82
US$4.06
EPS Growth
+3.6%
+6.2%
Revenue Estimate
US$21.3B
US$22.0B
Revenue Growth
+4.7%
+3.3%
Number of Analysts
18
19
| Metric | Value | Description |
|---|---|---|
| P/E Ratio (TTM) | 33.18 | The trailing price-to-earnings ratio measures the current share price relative to the company's earnings per share over the past 12 months, indicating how much investors are willing to pay for each dollar of earnings. |
| Forward P/E | 21.42 | The forward price-to-earnings ratio measures the current share price relative to estimated future earnings, providing insight into investor expectations for future profitability. |
| PEG Ratio | 1.53 | The price/earnings to growth ratio compares the P/E ratio to the earnings per share growth rate, used to determine a stock's value while accounting for expected earnings growth. |
| Price/Sales (TTM) | 3.37 | The price-to-sales ratio compares the company's market capitalization to its revenue over the past 12 months, useful for valuing companies with volatile earnings or in early growth stages. |
| Price/Book (MRQ) | 1302.39 | The price-to-book ratio compares the company's market price to its book value per share from the most recent quarter, indicating how much investors are willing to pay for each dollar of book value. |
| EV/EBITDA | 16.01 | Enterprise value to EBITDA compares the total value of the company, including debt, to its earnings before interest, taxes, depreciation, and amortization, often used to compare companies across industries. |
| Return on Equity (TTM) | 363.58 | Return on equity measures the net income returned as a percentage of shareholder equity over the past 12 months, showing how efficiently a company uses shareholders' investments to generate profits. |
| Operating Margin | 17.62 | Operating margin measures the percentage of revenue remaining after paying for variable costs of production, indicating a company's operating efficiency and pricing power. |
| Company | Market Cap (B) | P/E Ratio | P/B Ratio | Revenue Growth (%) | Operating Margin (%) |
|---|---|---|---|---|---|
| Colgate-Palmolive (CL) (Target) | 70.01 | 33.18 | 1302.39 | 8.4% | 17.6% |
| Procter & Gamble (PG) | 342.91 | 21.54 | 6.38 | 3.3% | 25.3% |
| Unilever PLC (UL) | 127.20 | 19.57 | 6.86 | 3.5% | 20.0% |
| Kimberly-Clark Corporation (KMB) | 33.08 | 16.23 | 21.74 | -2.1% | 12.7% |
| Sector Average | — | 19.11 | 11.66 | 1.6% | 19.4% |